Stay updated on PembROlizuMab vs Chemo in MPM Clinical Trial
Sign up to get notified when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.

Latest updates to the PembROlizuMab vs Chemo in MPM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. This appears to be a minor maintenance update with no impact on study details or user-visible information.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded the VANTAGE-014 publication reference (Lancet Oncology, 2015) and updated to revision v3.4.1 in the Publications section; removed the Lancet Oncology erratum and the prior revision (v3.4.0).SummaryDifference0.1%

- Check74 days agoChange DetectedUI changes include Show glossary / Hide glossary controls, capitalization tweaks to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new revision tag (Revision: v3.4.0) replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedFooter shows Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to PembROlizuMab vs Chemo in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.